Tim Kutzkey is 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 18 open-market trades across 3 companies since 2019, most recently 2026-01-20.
CIK 0001614186
17 open-market purchases totalling $29.7M since 2019, against 1 sale. Across 17 scored buys the stock is up 34.0% at ninety days, and 31.2 points ahead of the S&P over the same stretch.
17 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RAPT | 1,236,261 | $71.7M |
| SRZN | 900,292 | $21.1M |
| NGM | 1,000 | $2K |
| Total | $92.8M |
Shares reported on the most recent Form 4, priced at the 2026-01-20 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 59% | 65% | 76% |
| Avg Move | +3.4% | +12.0% | +34.0% |
| Alpha | +4.9% | +13.6% | +31.2% |
| Scored | 17 | 17 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SRZN | BUY | 2026-01-15 | 2026-01-20 | $19.74 | $642K | +11.2% | +39.0% | +66.4% |
| SRZN | BUY | 2026-01-13 | 2026-01-15 | $19.86 | $357K | +5.7% | +19.6% | +56.1% |
| SRZN | BUY | 2026-01-06 | 2026-01-08 | $19.89 | $300K | -2.8% | +12.2% | +31.4% |
| SRZN | BUY | 2025-12-04 | 2025-12-08 | $19.37 | $1.3M | +0.9% | -6.2% | +28.6% |
| SRZN | BUY | 2025-11-13 | 2025-12-02 | $12.65 | $8.0M | +52.5% | +33.7% | +77.4% |
| SRZN | BUY | 2024-04-04 | 2024-04-17 | $15.50 | $6.0M | -1.4% | +1.4% | +0.8% |
| NGM | BUY | 2023-11-15 | 2023-11-17 | $0.69 | $16K | +11.5% | +17.8% | +122.4% |
| NGM | BUY | 2022-11-03 | 2022-11-07 | $4.92 | $1.4M | -5.7% | -3.3% | -7.1% |
| RAPT | BUY | 2022-05-25 | 2022-05-27 | $12.45 | $24K | +8.1% | +28.6% | +108.2% |
| NGM | BUY | 2020-08-27 | 2020-08-31 | $17.83 | $2.2M | -3.3% | -14.7% | +27.1% |
| RAPT | SELL | 2020-08-17 | 2020-08-19 | $22.75 | $24.5M | +4.4% | +47.0% | -35.5% |
| NGM | BUY | 2020-04-08 | 2020-04-09 | $14.95 | $3.4M | +5.0% | +45.4% | +29.9% |
| NGM | BUY | 2020-03-02 | 2020-03-04 | $17.97 | $2.3M | -34.7% | -31.6% | +11.9% |
| NGM | BUY | 2020-02-06 | 2020-02-10 | $15.96 | $717K | -1.0% | -6.1% | +35.8% |
| NGM | BUY | 2019-08-05 | 2019-08-07 | $13.98 | $167K | +7.0% | +12.9% | -9.4% |
| NGM | BUY | 2019-07-29 | 2019-07-31 | $13.68 | $768K | -4.1% | +26.0% | -8.1% |
| NGM | BUY | 2019-07-19 | 2019-07-23 | $13.54 | $1.4M | +8.6% | +33.8% | -10.2% |
| NGM | BUY | 2019-06-19 | 2019-06-21 | $13.91 | $742K | +0.4% | -5.2% | +17.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.